Position in WAT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$5,265,561
New position
Shares Held
14,040
first reported quarter
Ownership
0.014%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
#267
of 1,173 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026BRAIDWELL LP holds $238,238,242 across 8 Diagnostics & Research names. WAT ranks #8 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NEO |
Neogenomics Inc
|
4,918,202 | $71,756,567 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
89,395 | $44,819,077 | |
| 3 | CDNA |
CareDx, Inc.
|
1,220,602 | $34,787,157 | |
| 4 | DHR |
Danaher Corp /De/
|
150,627 | $28,691,430 | |
| 5 | GH |
Guardant Health, Inc.
|
147,850 | $22,181,935 | |
| 6 | NTRA |
Natera, Inc.
|
79,500 | $21,580,275 | |
| 7 | DGX |
Quest Diagnostics Inc
|
43,200 | $9,156,240 | |
| 8 | WAT |
Waters Corp /De/
This page
|
14,040 | $5,265,561 |
All Filings in WAT
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,265,561 | 14,040 | Shares | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||